2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow EVP 1001-1: new trials by email Literature Review of EVP 1001-1 trials Research Report on EVP 1001-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Manganese-Enhanced MRI (MEMRI) to Assess Peri-Infarct Injury Manganese-enhanced MRI contrast reagent, Gadolinium-enhanced MRI contrast reagent - ISCHEMIC CARDIOMYOPATHY | Phase 1 / Phase 2 | Completed | Stanford University | 33 | 2015-04-01 | 2020-02-17 |
| Safety and Efficacy of SeeMore (TM) in Heart Patients SeeMore(TM) - Myocardial Infarction | Phase 2 | Completed | Eagle Vision Pharmaceutical Corp. | 24 | 2008-06-01 | 2016-02-04 |
Myocardial Infarction (2) · Heart Diseases (1)
Eagle Vision Pharmaceutical Corp. (1) · Stanford University (1)
United States (1)